T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$2.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 3 |
Broadcom
AVGO
|
+$1.61B |
| 4 |
Tesla
TSLA
|
+$1.59B |
| 5 |
Sempra
SRE
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.14B |
| 2 |
Amazon
AMZN
|
+$2.54B |
| 3 |
AET
Aetna Inc
AET
|
+$1.44B |
| 4 |
Biogen
BIIB
|
+$1.4B |
| 5 |
Netflix
NFLX
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.6% |
| 2 | Healthcare | 16.34% |
| 3 | Financials | 16.13% |
| 4 | Consumer Discretionary | 14.78% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
1351
DELISTED
Natus Medical Inc
NTUS
| $9.05M | ﹤0.01% |
269,009
-128,076
| -32% | -$4.05M |
|
|
WBC
1352
DELISTED
WABCO HOLDINGS INC.
WBC
| $9.04M | ﹤0.01% |
67,514
+1,995
| +3% | +$289K |
|
|
FBMS
1353
DELISTED
The First Bancshares, Inc.
FBMS
| $8.99M | ﹤0.01% |
278,826
+38,032
| +16% | +$1.24M |
|
1354
STRATTEC Security
STRT
$340M
| $8.96M | ﹤0.01% |
246,364
+282
| +0.1% | +$10.9K |
|
1355
BBVA Argentina
BBAR
$3.17B
| $8.87M | ﹤0.01% |
388,830
+91,850
| +31% | +$2.2M |
|
1356
Markel Group
MKL
$22.8B
| $8.83M | ﹤0.01% |
7,546
+630
| +9% | +$709K |
|
1357
Assembly Biosciences
ASMB
$626M
| $8.82M | ﹤0.01% |
+14,956
| New | +$9.27M |
|
|
MDSO
1358
DELISTED
Medidata Solutions, Inc.
MDSO
| $8.82M | ﹤0.01% |
140,358
+19,610
| +16% | +$1.31M |
|
1359
REX American Resources
REX
$1.45B
| $8.62M | ﹤0.01% |
710,136
+432
| +0.1% | +$5.9K |
|
|
OLBK
1360
DELISTED
Old Line Bancshares, Inc.
OLBK
| $8.48M | ﹤0.01% |
257,062
+32,817
| +15% | +$1.04M |
|
|
TWTR
1361
DELISTED
Twitter, Inc.
TWTR
| $8.48M | ﹤0.01% |
292,208
+1,379
| +0.5% | +$40.4K |
|
1362
Rhythm Pharmaceuticals
RYTM
$7.96B
| $8.42M | ﹤0.01% |
423,049
+118,922
| +39% | +$3.16M |
|
|
NFX
1363
DELISTED
Newfield Exploration
NFX
| $8.32M | ﹤0.01% |
340,653
-2,784
| -0.8% | -$78.1K |
|
1364
AngioDynamics
ANGO
$647M
| $8.17M | ﹤0.01% |
473,856
+78,704
| +20% | +$1.31M |
|
|
ASRT
1365
DELISTED
Assertio
ASRT
| $7.94M | ﹤0.01% |
20,088
+2,543
| +14% | +$1.11M |
|
1366
World Kinect Corp
WKC
$1.87B
| $7.85M | ﹤0.01% |
319,716
-303,416
| -49% | -$7.8M |
|
1367
Enbridge
ENB
$111B
| $7.83M | ﹤0.01% |
248,955
-21,919
| -8% | -$767K |
|
1368
Regenxbio
RGNX
$687M
| $7.82M | ﹤0.01% |
262,121
+7,054
| +3% | +$205K |
|
1369
TripAdvisor
TRIP
$1.27B
| $7.81M | ﹤0.01% |
191,105
-4,315,737
| -96% | -$169M |
|
1370
Star Group
SGU
$411M
| $7.8M | ﹤0.01% |
+833,890
| New | +$8.29M |
|
1371
Dell
DELL
$318B
| $7.53M | ﹤0.01% |
366,269
+70,645
| +24% | +$1.52M |
|
1372
Williams-Sonoma
WSM
$28.7B
| $7.48M | ﹤0.01% |
283,486
-7,116
| -2% | -$188K |
|
1373
Genpact
G
$5.72B
| $7.43M | ﹤0.01% |
232,408
-13,246
| -5% | -$430K |
|
1374
Zscaler
ZS
$29.9B
| $7.39M | ﹤0.01% |
+263,437
| New | +$7.71M |
|
1375
Denali Therapeutics
DNLI
$3.9B
| $7.32M | ﹤0.01% |
+371,806
| New | +$7.64M |
|
Similar funds
T. Rowe Price Associates's Q1 2018 Portfolio in Review
As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
- T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
- T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
- T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
- T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
- T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.
Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.